Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Atreca, Inc. Class A Common Stock (BCEL)

Pharmaceutical Preparations

https://www.atreca.com

Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. It has single segment business of therapeutic drug discovery and development. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target derived from an antibody identified using its discovery platform.

835 INDUSTRIAL ROAD,, SUITE 400
SAN CARLOS, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/20/2019

Market Cap

3,568,788

Shares Outstanding

32,909,999

Weighted SO

39,624,075

Total Employees

N/A

Upcoming Earnings

06/19/2024

Beta

1.0260

Last Div

0.0000

Range

0.052-1.2

Chg

-0.0012

Avg Vol

267000

Mkt Cap

3568788

Exch

NASDAQ

Country

US

Phone

650 595 2595

DCF Diff

2.1031

DCF

3.6731

Div Yield

0.0000

P/S

13.5695

EV Multiple

0.1596

P/FV

0.3292

Div Yield %

0.0000

P/E

-0.0373

PEG

-0.0018

Payout

0.0000

Current Ratio

1.5846

Quick Ratio

1.4054

Cash Ratio

0.8644

DSO

710.5703

DIO

43.1193

Op Cycle

753.6897

DPO

223.6919

CCC

529.9978

Gross Margin

-24.2015

Op Margin

-228.4449

Pretax Margin

-371.6958

Net Margin

-361.5095

Eff Tax Rate

-0.1773

ROA

-3.6093

ROE

-1.9522

ROCE

-5.5843

NI/EBT

0.9726

EBT/EBIT

1.6271

EBIT/Rev

-228.4449

Debt Ratio

0.0486

D/E

0.1191

LT Debt/Cap

0.0000

Total Debt/Cap

0.1064

Int Coverage

22.4267

CF/Debt

-50.8017

Equity Multi

2.4484

Rec Turnover

0.5137

Pay Turnover

1.6317

Inv Turnover

8.4649

FA Turnover

0.1629

Asset Turnover

0.0100

OCF/Share

-1.6536

FCF/Share

-1.6614

Cash/Share

0.5435

OCF/Sales

-247.4411

FCF/OCF

1.0047

CF Coverage

-50.8017

ST Coverage

-50.8017

CapEx Coverage

-211.2890

Div&CapEx Cov

-211.2890

P/BV

0.3292

P/B

0.3292

P/S

13.5695

P/E

-0.0373

P/FCF

-0.0546

P/OCF

-0.0544

P/CF

-0.0544

PEG

-0.0018

P/S

13.5695

EV Multiple

0.1596

P/FV

0.3292

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation